Significance of Dermoscopy in Association with Clinical Features in Differentiation of Basal Cell Carcinoma and Benign Trichoblastic Tumours.
basal cell carcinoma
dermatoscopy
dermoscopy
desmoplastic trichoepithelioma
trichoblastic tumour
trichoblastoma
trichoepithelioma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
17 Aug 2022
17 Aug 2022
Historique:
received:
03
07
2022
revised:
08
08
2022
accepted:
10
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Background: Although basal cell carcinoma (BCC) can, in the majority of cases, be diagnosed based on clinical and dermoscopic assessment, a potential overlap with benign adnexal skin tumours seems to exist, including trichoblastic tumours (TT). Methods: Retrospective analysis of clinical and dermoscopic features of benign TT and BCC cases was performed to develop a diagnostic algorithm with a potential utility in clinical practice. Results: In the study, 502 histopathologically confirmed BCC cases were compared with 61 TT (including 44 TB (72.13%), 10 TE (16.39%) and 7 DTE (11.48%]). Patients in the BCC group were statistically older (mean age was 71.4 vs. 64.4 years, respectively; p = 0.009). BCC presented generally as larger tumours (mean tumour size 11.0 vs. 8.2 mm for the TT group; p = 0.001) and was more frequently associated with clinically visible ulceration (59.4% vs. 19.7%, respectively; p < 0.001). Comparison of lesion morphology, clinically visible pigmentation, and anatomical location did not show significant differences between the analysed groups. Dermoscopically visible ulceration was significantly more common in the BCC group compared to the TT group (52.2% vs. 14.8%; p < 0.0001). Pigmented structures, specifically brown dots and brown globules, were significantly more prevalent in the TT group (32.8% vs. 11.4%; p = 0.0001 and 29.5% vs. 8.2%; p <0.0001). Similarly, TT more commonly than BCC showed the presence of cloudy/starry milia-like cysts (26.2% vs. 11.6%; p = 0.0031) and yellow globules (16.4% vs. 7.2%; p = 0.033). Conclusions: Despite differences in frequency of clinical and dermoscopic features between BCC and TT in the studied group, differential diagnosis based on these variables is not reliable. Histopathological examination remains a diagnostic gold standard in differentiation of BCC and TT.
Identifiants
pubmed: 36010957
pii: cancers14163964
doi: 10.3390/cancers14163964
pmc: PMC9406107
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical University of Gdańsk, "Excellence Initiative-Research University"
ID : grant No. MNiSW 07/IDUB/2019/94.
Références
Br J Dermatol. 2015 Dec;173(6):1371-80
pubmed: 26211438
J Am Acad Dermatol. 2015 Jan;72(1 Suppl):S13-5
pubmed: 25500026
Dermatol Pract Concept. 2014 Jul 31;4(3):11-24
pubmed: 25126452
Int J Dermatol. 2021 Mar;60(3):e83-e84
pubmed: 32686120
Am J Dermatopathol. 2021 Dec 1;43(12):887-897
pubmed: 34797788
J Am Acad Dermatol. 2019 Feb;80(2):303-317
pubmed: 29782900
Actas Dermosifiliogr. 2015 Nov;106(9):e45-8
pubmed: 26032870
J Eur Acad Dermatol Venereol. 2014 Jul;28(7):933-42
pubmed: 23889040
J Eur Acad Dermatol Venereol. 2019 May;33(5):e201-e203
pubmed: 30720895
Cureus. 2020 May 25;12(5):e8272
pubmed: 32596088
J Am Acad Dermatol. 2019 Feb;80(2):321-339
pubmed: 29782901
Dermatology. 2022;238(4):692-710
pubmed: 35026769
Exp Ther Med. 2022 Jan;23(1):60
pubmed: 34917186
J Eur Acad Dermatol Venereol. 2014 May;28(5):651-4
pubmed: 23332004
Acta Derm Venereol. 2010 Jul;90(4):436-7
pubmed: 20574623
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1978-1980
pubmed: 27439654
Am J Dermatopathol. 2022 Mar 1;44(3):190-195
pubmed: 34966051
Postepy Dermatol Alergol. 2019 Oct;36(5):572-580
pubmed: 31839774
Diagnostics (Basel). 2022 Mar 18;12(3):
pubmed: 35328289
Skin Res Technol. 2021 Mar;27(2):283-284
pubmed: 32702780
Dermatology. 2013;226(2):101-4
pubmed: 23363889
Dermatol Surg. 2015 Apr;41(4):522-5
pubmed: 25775446
J Am Acad Dermatol. 2021 Jan;84(1):17-31
pubmed: 32565210
Clin Exp Dermatol. 2021 Dec;46(8):1471-1481
pubmed: 34047380
JAMA Dermatol. 2020 Aug 1;156(8):882-890
pubmed: 32459294
Arch Dermatol Res. 2021 Apr;313(3):193-200
pubmed: 32020324
Clin Exp Dermatol. 2018 Apr;43(3):241-247
pubmed: 29341291
Clin Exp Dermatol. 2017 Dec;42(8):906-909
pubmed: 28976013
Dermatology. 2007;215(4):354-8
pubmed: 17911996